β-Cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes

Diabetes

Volumn 49, Issue 12, 2000, Pages 2056-2062

  Andrikopoulos, Sofianos ^a   Verchere, C Bruce ^a,d   Terauchi, Yasuo ^b   Kadowaki, Takashi ^b   Kahn, Steven E ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; GLUCOKINASE; GLUCOSE;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME DEFICIENCY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; KNOCKOUT MOUSE; LIPID DIET; MALE; MATURITY ONSET DIABETES MELLITUS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033669527     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.12.2056     Document Type: Article

References (33)

1. Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes
2. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas
3. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
4. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells
5. Two novel immortal pancreatic β-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid
6. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation
7. Pancreatic expression and secretion of human IAPP in a transgenic mouse
8. Transgenic mice overproducing human islet amyloid polypeptide have increased insulin storage and secretion in vitro
9. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide
10. Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in viva in rats
11. Banting Lecture 1990: β-cells in type II diabetes mellitus
12. Pancreatic β-cell-specific targeted disruption of glucokinase gene
13. Transgene detection in mouse tail digests
14. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β cell glucokinase genes
15. Immunoassay of insulin: Two antibody system, plasma insulin levels of normal, subdiabetic, and diabetic rats
16. Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma
17. Islet amyloid polypeptide: A novel controversy in diabetes research
18. Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway
19. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle
20. Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice
21. Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
22. Analysis of the pancreatic β cell in the mouse with targeted disruption of the pancreatic β cell-specific glucokinase gene
23. Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice
24. Islet amyloid-associated diabetes in A(vy/a) mice expressing human islet amyloid polypeptide
25. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model
26. Consequence of human IAPP expression in transgenic mice
27. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglcaemia or hyperinsulinaemia
28. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
29. B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro
30. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation
31. β-Cell dysfunction induced by chronic hyperglycaemia
32. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations
33. Pancreatic pathology hi non-insulin dependent diabetes (NIDDM)